Alive & Thrive Nigeria Impact Evaluation

January 13, 2021 updated by: RTI International
Investigators will use a cluster-randomized design to evaluate the overall impact of the Alive & Thrive infant and young child feeding communication strategies in Lagos and Kaduna States, Nigeria. The impact in each state and in a subset of urban local government areas (LGAs) will also be tested.This is a mixed methods evaluation; the quantitative data will be complemented by qualitative data obtained from different groups targeted by or involved in the program.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Adequate nutrition during the first 1,000 days is necessary for children to grow and develop to their full potential. Alive & Thrive (A&T) contributes to better nutrition during the first 1,000 days by promoting improved infant and young child feeding (IYCF) practices. A&T is expanding its efforts to Nigeria and will target Lagos and Kaduna States. In Nigeria, 33% of infants are breastfed within 1 hour of delivery, 60% are given other fluids in the first 3 days of life, and only 17% of children 0-5.9 months are exclusively breastfed. Approximately 60% of children 6 to 23 months achieve the minimum meal frequency for their age and 19% are fed four or more food groups per day. To address these gaps in optimal IYCF practices, A&T will use an implementation framework for IYCF impact at scale that includes advocacy, interpersonal communication and community mobilization, mass communication, and strategic use of data. The A&T intervention will be compared to mass media communication on IYCF, which will be provided throughout the two states. LGAs in Lagos and Kaduna will be randomly allocated such that two-thirds receive the A&T intervention and one-third are assigned to the comparison group. The primary objectives of the evaluation are to measure the impact of the A&T intervention on IYCF practices among mothers with children 0-23 months of age overall, in each state, and in a subset of urban LGAs. Secondary evaluation objectives are to document: the type, quantity, and timing of the implementation of A&T program activities; coverage levels A&T achieves with different program activities; extent to which A&T increases knowledge and awareness of optimal IYCF practices among women with children 0 to 23 months and health providers; extent to which A&T improves the capacity of health providers to counsel mothers on IYCF; and extent to which A&T improves the capacity of stakeholders to implement community-based activities that support optimal IYCF practices.

Study Type

Interventional

Enrollment (Actual)

15169

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaduna, Nigeria
        • Kantar TNS RMS
    • Lagos
      • Ikeja, Lagos, Nigeria
        • Kantar TNS RMS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 49 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • For mother's survey:
  • Women of reproductive age (15-49 years),
  • Must be married if 15-17 years,
  • Has a child 0-23 months
  • For provider's survey:
  • Male or female,
  • 18 years or older
  • Works in a government or private health facility or works as a community pharmacist, private patent medicine vendor, or traditional birth attendant

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention.
Experimental: A&T IYCF intervention
A&T IYCF intervention is includes comprehensive IYCF counseling which includes intensive activity that aims to deliver one-on-one counseling at home or in a health facility.
(1) Interpersonal communication through frontline workers/volunteers to increase mothers' knowledge and practice of optimal infant and young child feeding (IYCF) behaviors. Interpersonal communication will involve multiple contacts with mothers and an array of IYCF messages; (2) Community mobilization activities to raise awareness of the benefits of optimal IYCF practices among opinion leaders and family members, and increase their support to mother for IYCF; (3) Training of facility and community-based health workers on IYCF to improve their ability to support mothers and provide timely information on IYCF; and (4) Mass media communication on IYCF.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exclusive breastfeeding on the day preceding the interview.
Time Frame: 2 years
The proportion of infants 0-5 months who were exclusively breastfed on the previous day.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exclusive breastfeeding from 0-5 months.
Time Frame: 2 years
The proportion of children who were exclusively breastfed from 0-5 months.
2 years
Breastfeeding within 1 hour of birth.
Time Frame: 2 years
The proportion of children 0-23 months who were breastfed within 1 hour of birth.
2 years
Minimum dietary diversity.
Time Frame: 2 years
The proportion of children 6-23 months who were fed the minimum number of food groups on the previous day based on the WHO infant and young child feeding guidelines.
2 years
Minimum meal frequency.
Time Frame: 2 years
Description: The proportion of children 6-23 months who were fed the minimum number of meals on the previous day based on the World Health Organization infant and young child feeding guidelines.
2 years
Mothers' accurate knowledge of optimal infant and young child feeding practices.
Time Frame: 2 years

Mothers' accurate knowledge of:

  • Optimal timing of breastfeeding initiation
  • Optimal duration of exclusive breastfeeding
  • Solution to common breastfeeding problems
  • Optimal timing to introduce complementary foods
  • Optimal dietary diversity and frequency of complementary feeding from 6-23 months
2 years
Health providers' knowledge of optimal infant and young child feeding practices.
Time Frame: 2 years

Providers' accurate knowledge of:

  • Optimal timing of breastfeeding initiation
  • Optimal duration of exclusive breastfeeding
  • Solution to common breastfeeding problems
  • Optimal timing to introduce complementary foods
  • Optimal dietary diversity and frequency of complementary feeding from 6-23 months
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Valerie Flax, RTI International
  • Principal Investigator: Mariam Fagbemi, TNS RMS Nigeria, Ltd.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 19, 2017

Primary Completion (Actual)

December 2, 2020

Study Completion (Actual)

December 2, 2020

Study Registration Dates

First Submitted

October 19, 2016

First Submitted That Met QC Criteria

November 23, 2016

First Posted (Estimate)

November 29, 2016

Study Record Updates

Last Update Posted (Actual)

January 14, 2021

Last Update Submitted That Met QC Criteria

January 13, 2021

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 08100206

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complementary Feeding

Clinical Trials on A&T IYCF intervention

3
Subscribe